EP1786794A2 - Biphenyl-thiazol-carboxamides - Google Patents

Biphenyl-thiazol-carboxamides

Info

Publication number
EP1786794A2
EP1786794A2 EP05770051A EP05770051A EP1786794A2 EP 1786794 A2 EP1786794 A2 EP 1786794A2 EP 05770051 A EP05770051 A EP 05770051A EP 05770051 A EP05770051 A EP 05770051A EP 1786794 A2 EP1786794 A2 EP 1786794A2
Authority
EP
European Patent Office
Prior art keywords
alkyl
carbonyl
alkoxy
formula
chlorine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05770051A
Other languages
German (de)
English (en)
Inventor
Ralf Dunkel
Hans-Ludwig Elbe
Jörg Nico GREUL
Benoit Hartmann
Herbert Gayer
Thomas Seitz
Ulrike Wachendorff-Neumann
Peter Dahmen
Karl-Heinz Kuck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Publication of EP1786794A2 publication Critical patent/EP1786794A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Definitions

  • the present invention relates to novel Biphenylthiazolcarboxamide, several processes for their preparation and their use for controlling unwanted microorganisms.
  • the effectiveness of these substances is good, but can in some cases, for example in low application rates to be desired.
  • R 1 is hydrogen, halogen, amino, C 1 -C 4 -alkylamino, di- (C 1 -C 4 -alkyl) amino, cyano, C r C 4 -
  • R 2 represents halogen
  • Ci-C 4 -alkyl or C is 4 -halogenoalkyl having 1 to 5 halogen atoms
  • R 3 is hydrogen, C r C 8 alkyl, C r C 6 alkylsulfinyl, C r C 6 alkylsulfonyl, C 1 -C 4 -alkoxy-C 1 -C 4 - alkyl, C 3 -CG-cycloalkyl; C r C 6 haloalkyl, C r C 4 haloalkylthio, Ci-C 4 haloalkyl sulfinyl, C] -C 4 -haloalkylsulfonyl, halo-Ci-C4-alkoxy-Ci-C 4 alkyl, C 3 - C 9 -halogeno-cycloalkyl having in each case 1 to 9 fluorine, chlorine and / or bromine atoms; Formyl, formyl--C 3 - alkyl, (Ci-C3-alkyl) carbonyl-Ci-C3 alkyl, (Ci-C 3 al
  • R 4 is halogen, C r C 4 alkyl, Ci-C 4 alkoxy, C r C 4 -alkylthio or C r C 4 haloalkyl having 1 to
  • R 5 represents halogen, cyano, nitro, amino, hydroxyl, formyl, carboxyl, carbamoyl, thiocarbamoyl, Ci-Cg-alkyl, C 2 -C 6 alkenyl, C r C 8 alkoxy, C 2 -C 6 alkenyloxy, dQ alkylthio, C 1 -C 8 - alkylsulphinyl, C, -C 8 alkylsulfonyl, C r C 8 hydroxyalkyl, C, -C 8 -oxoalkyl, C r C alkyl -Alkoxyal- 8, C r C 8 alkylthioalkyl , C r C 8 -Dialkoxyalkyl, Ci-C6 alkylamino, di (C r C 6 alkyl) amino, (CrC 6 alkyl) carbonyl, (C r C 6 alkyl) carbonyloxy, (C r
  • Haloalkylthio, CrC ö haloalkylsulfinyl or Ci-C ⁇ -haloalkylsulfonyl having in each case 1 to 13 halogen atoms, C 2 -C 6 haloalkenyl, C 2 -C 6 haloalkenyloxy same, each having 1 to 11 or different halogen atoms,
  • R 5 also represents optionally mono- or disubstituted by halogen, Ci-C 4 alkyl or C r C 4 - alkenylene when two - halogenoalkyl having 1 to 5 halogen atoms substituted C 2 -C 5
  • Radicals R 5 are ortho to one another, n is 2, 3, 4 or 5, where R 5 may be the same or different,
  • R 6 is hydrogen, Ci-C 8 alkyl, C, -C 8 alkoxy, C, -C 4 alkoxy-C r C 4 alkyl, C 3 -C 8 cycloalkyl; C r C 6 haloalkyl, C r C 6 haloalkoxy, halogen-Ci-C 4 -alkoxy-C r C 4 alkyl, C 3 -C 8 -HaIo- gencycloalkyl each having 1 to 9 fluorine, chlorine and / or bromine atoms stands,
  • R 7 and R 8 are each independently hydrogen, Ci-C 8 alkyl, Ci-C4-alkoxy-Ci-C 4 alkyl, C 3 -C 8 cycloalkyl; C r C 8 haloalkyl, halogen-CrC 4 alkoxy-C, -C 4 alkyl, halo-C 3 -C 8 cycloalkyl with in each case 1 to 9 fluorine, chlorine and / or bromine atoms,
  • R 7 and R 8 together with the nitrogen atom to which they are attached additionally form a saturated heterocycle having 5 to 8 ring atoms, which is optionally mono- or polysubstituted by identical or different halogen or C 1 -C 4 -alkyl, where the hetero cyclus may contain 1 or 2 further non-adjacent heteroatoms selected from oxygen, sulfur or NR 11 ,
  • R 9 and R 10 independently of one another represent hydrogen, C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl; C r C 8 -haloalkyl, C 3 -Cg-halogenocycloalkyl having in each case 1 to 9 fluorine, chlorine and / or bromine atoms,
  • R 9 and R 10 together with the nitrogen atom to which they are attached additionally form a saturated heterocycle having 5 to 8 ring atoms, which is optionally mono- or polysubstituted, identically or differently, by halogen or C 1 -C 4 -alkyl, where the hetero ⁇ cyclus can contain 1 or 2 further non-adjacent heteroatoms from the series oxygen, sulfur or NR 1 ',
  • R 11 is hydrogen or C r C 6 alkyl.
  • R 1 and R 2 have the meanings given above and
  • X 1 is halogen or hydroxy, with biphenylamines of the formula (HI)
  • R 3 , R 4 , R 5 and n have the abovementioned meanings, if appropriate in the presence of a catalyst, if appropriate in the presence of a condensing agent, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent, or
  • R 1 , R 2 , R 3 and R 4 have the meanings given above,
  • X 2 is bromine, iodine or trifluoromethylsulfonate, with boronic acid derivatives of the formula (V)
  • R 5 and n have the meanings given above and
  • G 1 and G 2 are each hydrogen or together are tetramethylethylene, in the presence of a catalyst, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent, or
  • R 1 , R 2 , R 3 and R 4 have the meanings given above,
  • G 3 and G 4 are each hydrogen or together are tetramethylethylene, with phenyl derivatives of the formula (VE)
  • R 5 and n have the meanings given above and
  • X 3 represents chlorine, bromine, iodine or trifluoromethylsulfonate, in the presence of a catalyst, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent, or
  • X 2 is bromine, iodine or trifluoromethylsulfonate, with phenyl derivatives of the formula (VH)
  • X 3 is chlorine, bromine, iodine or trifluoromethylsulfonate, in the presence of a palladium or nickel catalyst and in the presence of
  • Acid binder and, if appropriate, in the presence of a diluent, or
  • R 3A represents C 1 -C 8 -alkyl, C, -C 6 alkylsulfinyl, C r C 6 alkylsulfonyl, CrC 4 -alkoxy-Ci-C 4 -AL- alkyl, C 3 -C 8 cycloalkyl; QQ-haloalkyl, C] -C 4 haloalkylthio, C r C 4-halo-alkylsulfinyl, C r C 4 -haloalkylsulfonyl, halo-Ci-C4-alkoxy-Ci-C 4 alkyl, C 3 -C 8 -
  • Halocycloalkyl having in each case 1 to 9 fluorine, chlorine and / or bromine atoms; formyl,
  • R 6 , R 7 , R 8 , R 9 and R 10 have the meanings given above, X 4 is chlorine, bromine or iodine, in the presence of a base and in the presence of a diluent.
  • the novel biphenylthiazolecarboxamides of the formula (I) have very good microbicidal properties and can be used for controlling unwanted microorganisms both in crop protection and in the protection of materials.
  • the compounds according to the invention can be used as mixtures of various possible isomeric forms, in particular of stereoisomers, such as, for example, B. E and Z, threo and erythro, and optical isomers, but optionally also of tautomers. Both the E and the Z isomers, as well as the threo and erythro, and the optical isomers, any mixtures of these isomers, as well as the possible tautomeric forms are claimed.
  • the biphenylthiazolecarboxamides according to the invention are generally defined by the formula (I). Preferred radical definitions of the above and below formulas are given below. These definitions apply equally to the end products of formula (I) as well as to all intermediates.
  • R 1 preferably represents hydrogen, fluorine, chlorine, bromine, amino, C r C 4 alkylamino, di (C r C 4 - alkyl) amino, cyano, methyl, ethyl or Ci-C 2 haloalkyl having 1 to 5 fluorine , Chlorine and / or bromine atoms.
  • R 1 particularly preferably represents hydrogen, fluorine, chlorine, bromine, amino, methylamino,
  • R 1 very particularly preferably represents hydrogen, fluorine, chlorine, bromine, amino, methylamino,
  • R 1 particularly preferably represents amino, chlorine, methylamino, dimethylamino, methyl or
  • R 2 is preferably fluorine, chlorine, bromine, methyl, ethyl or C 1 -C 2 -haloalkyl having 1 to 5
  • R 2 particularly preferably represents fluorine, chlorine, bromine, methyl, ethyl, 1-fluoroethyl,
  • Trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl Trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
  • R 2 very particularly preferably represents fluorine, chlorine, bromine, methyl, trifluoromethyl, difluoromethyl or trichloromethyl.
  • R 2 is particularly preferably methyl, trifluoromethyl or difluoromethyl.
  • R 3 preferably represents hydrogen, Ci-C 6 alkyl, Ci-C 4 alkylsulfinyl, C r C 4 alkylsulfonyl, C 1 -C 3 - alkoxy-Ci-C 3 alkyl, C 3 -C 6 cycloalkyl ; C r C 4 haloalkyl, C r C 4 haloalkylthio, Ci-C 4 - haloalkylsulfinyl, Ci-C4-haloalkylsulfonyl, halo-Ci-C 3 alkoxy-Ci-C 3 alkyl, C 3 -C 8 - Halocycloalkyl having in each case 1 to 9 fluorine, chlorine and / or bromine atoms; Formyl, formyl C r C 3 alkyl, (C r C3-alkyl) carbonyl-C, -C 3 alkyl, (Ci-C 3 alkoxy) carbonyl
  • R 3 is particularly preferably hydrogen, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, pentyl or hexyl, methylsulfinyl, ethylsulfinyl, n- or iso-propylsulfinyl, n-, iso-, sec- or tert-butylsutfinyl, methylsulfonyl, ethylsulfonyl, n- or iso-propylsulfonyl, n-, iso-, sec- or tert-butylsulfonyl, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, cyclopropyl, cyclopentyl, cyclohexyl, trifluoromethyl, Trichloromethyl, trifluoroethy
  • R 3 very particularly preferably represents hydrogen, methyl, methoxymethyl, formyl, -CH 2 -CHO,
  • R 4 is preferably fluorine, with fluorine being particularly preferably in the 3- or 5-position, very particularly preferably in the 5-position of the respective compound [cf. eg formula (I)].
  • R 4 is preferably chlorine, with chlorine being particularly preferably in the 4- or 5-position, very particularly preferably in the 4-position, moreover very particularly preferably in the 5-position of the respective compound.
  • R 4 furthermore preferably represents trifluoromethyl, trifluoromethyl being particularly preferably in
  • R 4 furthermore preferably represents methoxy or methylthio, with methoxy or methylthio being particularly preferably in the 3- or 5-position, very particularly preferably in the 5-position of the respective compound.
  • R 4 furthermore preferably represents methyl, where methyl is more preferably in 4- or 5- Position, most preferably in the 4-position of the respective compound.
  • R 4 furthermore preferably represents isopropyl, isopropyl being particularly preferably in the 4- or 5-position, very particularly preferably in the 5-position of the respective compound.
  • R 5 is preferably fluorine, chlorine, bromine, cyano, nitro, amino, hydroxyl, formyl, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, vinyl, allyl, methoxy , Ethoxy, n- or iso-propoxy, vinyloxy, allyloxy, methylthio, ethylthio, n- or iso-propylthio, methylsulfinyl, ethylsulfinyl, n- or iso-propylsulfinyl, methylsulfonyl, ethylsulfonyl, n- or iso-propylsulfonyl, methoxymethyl , Methoxyethyl, ethoxymethyl, ethoxyethyl, methylthiomethyl, methylthioethyl, ethyl
  • R 5 also preferably represents optionally mono- or disubstituted by fluorine, chlorine, bromine, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl or trifluoromethyl-substituted C 2 -C 4 -alkenylene when two radicals R 5 are ortho to each other.
  • R 5 is particularly preferably fluorine, chlorine, bromine, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, methoxy, ethoxy, n- or iso-propoxy, methylthio, ethylthio , n- or iso-Propylthio, methylsulfonyl, ethylsulfonyl, n- or iso-propylsulfonyl, methoxymethyl, methylthiomethyl, methylamino, ethylamino, iso-propylamino, dimethylamino, diethylamino, diisopropylamino, methylcarbonyl, methylaminocarbonyl, dimethylaminocarbonyl, methylcarbonylamino, cyclopropyl, trifluoromethyl , Trifluoroethyl, difluorome
  • R 5 most preferably represents fluoro, chloro, bromo, methyl, iso-propyl, tert-butyl, methoxy, iso-propoxy, methylthio, iso-propylthio, methoxymethyl, methylthiomethyl, methylamino, dimethylamino, methylaminocarbonyl, methylcarbonylamino, cyclopropyl, trifluoromethyl , Trifluoroethyl, difluoromethoxy, trifluoromethoxy, difluoromethylthio or trifluoromethylthio.
  • R 5 particularly preferably represents fluorine, chlorine, bromine, methyl, trifluoromethyl, difluoromethoxy or trifluoromethoxy.
  • n is preferably 2, 3 or 4, where the radicals R 5 may be identical or different, n is particularly preferably 2 or 3, where the radicals R 5 may be identical or different. n is very particularly preferably 2, in particular in 3 ', 4' position, 2 ', 4' position, 3 ', 5' position, 2 ', 3' position or 2 ', 5' position, where the radicals R 5 can each be identical or different, n furthermore very particularly preferably stands for 3, in particular in the 2 ', 4', 6 'position or 3', 4 ', 5'
  • R 6 is preferably hydrogen, C r C 6 alkyl, C r C 4 alkoxy, Ci-GrAlkoxy CRCS alkyl, C 3 -
  • Ci-C 4 haloalkyl Ci-C 4 haloalkyl, Ci-C4 haloalkoxy, halogen-C r C 3 alkoxy-Ci-C 3 - alkyl, CyC ⁇ -halocycloalkyl having in each case 1 to 9 fluorine, chlorine and / or bromine atoms.
  • R 6 is particularly preferably hydrogen, methyl, ethyl, n- or iso-propyl, tert-butyl,
  • R 7 and R 8 independently of one another preferably represent hydrogen, C r C 6 alkyl, C] -C3 alkoxy-Ci- C 3 alkyl, C 3 -C 6 cycloalkyl; C 1 -C 4 -haloalkyl, halo-C 1 -C 3 -alkoxy-C r C 3 -alkyl, C 3 -C 6 -halocycloalkyl having in each case 1 to 9 fluorine, chlorine and / or bromine atoms.
  • R 7 and R 8 furthermore together with the nitrogen atom to which they are attached preferably form an optionally mono- to tetrasubstituted by identical or different manner by halogen or C r C 4 alkyl substituted saturated heterocycle having 5 or 6 ring atoms, wherein the hetero- cyclus may contain 1 or 2 further, non-adjacent heteroatoms from the series oxygen, sulfur or NR 1 '.
  • R 7 and R 8 independently of one another particularly preferably represent hydrogen, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, methoxymethyl, methoxyethyl, ethoxymethyl,
  • R 7 and R 8 also together with the nitrogen atom to which they are attached, more preferably form an optionally mono- to di-quadratic, identical or different, by fluorine,
  • Thiomorpholine or piperazine wherein the piperazine on the second nitrogen atom may be substituted by R 11 .
  • R 9 and R 10 are each independently preferably represents hydrogen, Ci-C 6 alkyl, C 3 -C 6 -Cycloal- alkyl; C r C 4 haloalkyl, C 3 -C 6 halocycloalkyl having in each case 1 to 9 fluorine, chlorine and / or bromine atoms.
  • R 9 and R 10 also form, together with the nitrogen atom to which they are bonded, preferably an optionally monosubstituted to quadruple, identical or different, by halogen or Cp
  • Heterocycle may contain 1 or 2 further non-adjacent heteroatoms from the series oxygen, sulfur or NR 11 .
  • R 9 and R 10 independently of one another particularly preferably represent hydrogen, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, cyclopropyl, cyclopentyl, cyclohexyl ; Trifluoromethyl, trichloromethyl, trifluoroethyl, trifluoromethoxymethyl.
  • ⁇ R 9 and R 10 together with the nitrogen atom to which they are attached moreover preferably form a saturated heterocycle from the series morpholine, thiomorpholine or piperazine which is optionally monosubstituted to monosubstituted, identically or differently by fluorine, chlorine, bromine or methyl, wherein the piperazine may be substituted on the second nitrogen atom by R 11 .
  • R 1 * is preferably hydrogen or C 1 -C 4 -alkyl.
  • R 11 is particularly preferably hydrogen, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl.
  • R 1 , R 2 , R 3A , R 4 , R 5 and n have the meanings given above.
  • R 3A is preferably fiir C r C 6 alkyl, Ci-C4 alkylsulfinyl, CRQ alkylsulfonyl, C 1 -C 3 -alkoxy-C Cr 3 alkyl, C 3 -C 6 cycloalkyl; Ci-C 4 haloalkyl, C r C 4 haloalkylthio, C r C 4 -Halogenal- kylsulfinyl, Ci-C4-haloalkylsulfonyl, halo-Ci-C 3 alkoxy-Ci-C 3 alkyl, C 3 -CG -Halogeno-cycloalkyl having in each case 1 to 9 fluorine, chlorine and / or bromine atoms; Formyl, formyl-C 3 - alkyl, (Ci-C 3 alkyl) carbonyl-Ci-C 3 alkyl, (C r C 3 alkoxy) carbonyl
  • R 3A particularly preferably represents methyl, ethyl, n- or isopropyl, n-, iso-, sec- or tert-butyl,
  • R 1 , R 2 , R 3 and R 4 have the meanings given above and R 5A and R 5B independently of one another have the meanings of R 5 .
  • R, R, R and R have the meanings given above and R and R 5B independently of one another have the meanings of R 5 .
  • R 1 , R 2 , R 3 and R 4 have the meanings given above and R 5A and R 5B independently of one another have the meanings of R 5 .
  • R 1 , R 2 , R 3 and R 4 have the meanings given above and R 5A , R 53 and R 5C independently of one another have the meanings of R 5 .
  • R> 1, RD 2 , r R> 3, R 5> and n have the meanings given above.
  • R 1 , R 2 , R 3 , R 5 and n have the meanings given above.
  • R 1 , R 2 , R 3 and R 4 have the meanings given above and R 5A and R ⁇ independently of one another have the meanings of R 5 .
  • R 1 , R 2 , R 3 and R 4 have the meanings given above and R 5A and R 5B independently of one another have the meanings of R 5 .
  • R 1 , R 2 , R 3 and R 4 have the meanings given above and R 5A and R 5B independently of one another have the meanings of R 5 .
  • R 1 , R 2 , R 3 and R 4 have the meanings given above and R 5A and
  • R> 5B independently of one another have the meanings of R.
  • Group 19 Biphenylthiazolecarboxamides of the formula (Is)
  • R 1 , R 2 , R 3 and R 4 have the meanings given above and R 5 ⁇ and R 5B independently of one another have the meanings of R 5 .
  • Fluorine, chlorine and / or bromine atoms Fluorine, chlorine and / or bromine atoms.
  • Saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl
  • heteroatoms e.g. in alkoxy, as far as possible, in each case straight-chain or branched.
  • dialkylamino also includes an unsymmetrically alkyl-substituted amino group, such as e.g. Methyl ethylamino.
  • Halogen substituted radicals e.g. Haloalkyl
  • Halogen substituted radicals are halogenated singly or multiply.
  • the halogen atoms may be the same or different.
  • Halogen stands for fluorine, chlorine, bromine and iodine, in particular fluorine, chlorine and bromine.
  • the carbonic acid derivatives required as starting materials for carrying out the process (a) according to the invention are generally defined by the formula (U).
  • R 1 and R 2 are preferred, particularly preferred or very particularly preferred meanings as preferred in connection with the description of the compounds of formula (T) according to the invention, particularly preferred and very particularly preferably these residues were indicated.
  • X 1 is preferably chlorine, bromine or hydroxyl.
  • the carboxylic acid derivatives of the formula (II) are known and / or can be prepared by known processes (cf., WO 03/066609, WO 03/066610, EP-A 0 545 099, EP-A 0 589 301, EP -A 0 589 313 and US 3,547,917).
  • the biphenylamines which are furthermore required as starting materials for carrying out the process (a) according to the invention are generally defined by the formula (III).
  • R 3, R 4, R 5 and n being preferred, particularly preferred and very particularly preferably have those meanings already mentioned in connection with the description of the compounds of formula (I) according to the invention for these radicals or this Index as preferred, particularly preferred or very particularly preferred.
  • biphenylamines of formula (HI) are known in part or may be obtained by known methods (see for example WO 03/070705, WO 97/08148, IP 2001-302605).
  • halo-carboxamides required for carrying out the process (b) according to the invention as starting materials are generally defined by the formula (TV).
  • R 1, R 2, R 3 and R 4 are preferred, particularly preferred and very particularly preferably have those meanings already mentioned in connection with the description of the compounds of formula (I) as being preferred, particularly preferably or very particularly preferred for these radicals ange ⁇ .
  • X 2 is bromine or iodine.
  • halo carboxamides of the formula (TV) are not yet known. They are also the subject of the present application as novel chemical compounds. They are obtained by reacting (f) carboxylic acid derivatives of the formula (TI)
  • R 3 , R 4 and X 2 have the meanings given above, if appropriate in the presence of a catalyst, if appropriate in the presence of a condensing agent, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent.
  • haloanilines which are furthermore required as starting materials for carrying out the process (f) according to the invention are generally defined by the formula (IX).
  • R 3, R 4 and X 2 are preferred, particularly preferred and very particularly preferred meanings, the formula already mentioned in connection with the description of the inventive compounds (I) or of the precursors of the formula (TV ) were given as preferred, particularly preferred or very particularly preferred for these radicals.
  • haloanilines of the formula (IX) are commercially available synthetic chemicals or can be obtained by known methods.
  • the boronic acid derivatives of the formula (V) are known and / or can be prepared by known processes (cf., for example, WO 01/90084, JP-A 2001-302605 and US 5,633,218).
  • Boron ⁇ acid derivatives are generally defined by the formula (VT).
  • R 1, R 2, R 3 and R 4 are preferred, particularly preferred and very particularly preferably have those meanings already mentioned in connection with the description of the compounds of formula (I) as being preferred, particularly preferably or very particularly preferred for these radicals.
  • G 3 and G 4 are each hydrogen or together are tetramethylethylene.
  • the boronic acid derivatives of the formula (VI) are not yet known. They are new chemical compounds and are also the subject of the present application. They are obtained by reacting (g) a carboxylic acid derivative of the formula (H)
  • R 1 , R 2 and X 1 have the meanings given above, with an anilinboronic acid derivative of the formula (X) in which R 3 , R 4 , G 3 and G 4 have the abovementioned meanings, if appropriate in the presence of a catalyst, if appropriate in the presence of a condensing agent, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent.
  • Anilinboronklare derivatives are generally defined by the formula (X).
  • R 3 and R 4 are preferred, particularly preferred or very particularly preferred meanings as preferred in connection with the description of the compounds of formula (T) according to the invention, particularly preferred and very particularly preferably these residues were indicated.
  • G 3 and G 4 are each hydrogen or together are tetramethylethylene.
  • aniline boronic acid derivatives of the formula (X) are known synthetic chemicals or can be obtained by known methods.
  • R 5 and n preferably, particularly preferred or very particularly preferred meanings as preferred (I) in connection with the description of the inventive compounds of the formula, particularly preferred or very particularly preferred for this Remainder or index were given.
  • X 3 is chlorine, bromine, iodine or trifluoromethylsulfonate.
  • the phenyl derivatives of formula (VTI) are known synthetic chemicals.
  • the 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bis-l, 3,2-dioxaborolane furthermore required for carrying out the process (d) according to the invention is a commercially available one chemical for synthesis.
  • R 1, R 2, R 4, R 5 and n have preferred, particularly preferred and very particularly preferably have those meanings which have already been in connection with the description of the comparison of the invention of formula (I) as preferred, particularly preferred or very particularly preferred for these radicals or this index.
  • the compounds of the formula (I-a) are compounds according to the invention and can be prepared by the processes (a) to (d).
  • halides which are furthermore required as starting materials for carrying out the process (e) according to the invention are generally defined by the formula (VHI).
  • R is 3 ⁇ vorzugt, particularly preferred and very particularly preferably has those meanings, which as preferred above for compounds of formula (Ib), particularly preferred or very particularly preferred for this radical indicated ,
  • X 4 is chlorine, bromine or iodine.
  • Suitable diluents for carrying out processes (a), (f) and (g) according to the invention are all inert organic solvents. These preferably include aliphatic, alicyclic or aromatic hydrocarbons, such as e.g. Petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; halogenated hydrocarbons, e.g.
  • Chlorobenzene dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane
  • Ethers such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole
  • Ketones such as acetone, butanone, methyl isobutyl ketone or cyclohexanone
  • Nitriles such as acetonitrile, propionitrile, n- or i-butyronitrile or benzonitrile
  • Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide; their mixture
  • the processes (a), (f) and (g) according to the invention are carried out in the presence of a suitable acid acceptor.
  • a suitable acid acceptor all customary inorganic or organic bases are suitable. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates or bicarbonates, for example sodium hydride, sodium amide, lithium diisopropylamide, sodium methoxide, sodium ethoxide, potassium tert-butoxide .
  • Sodium hydroxide, potassium hydroxide, sodium acetate, sodium carbonate, potassium carbonate, potassium hydrogencarbonate, sodium bicarbonate or ammonium carbonate, and tertiary amines such as trimethylamine, triethylamine, tributylamine, N, N-dimethylaniline, N, N-dimethylbenzylamine, pyridine, N-methylpiperidine, N -Methylmorpholine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU).
  • DABCO diazabicyclooctane
  • DBN diazabicyclononene
  • DBU diazabicycloundecene
  • the processes (a), (f) and (g) according to the invention are carried out in the presence of a suitable condensation agent.
  • a suitable condensation agent As such, all conventionally suitable for such Ami- d istsrevatiding agent come into question. Examples which may be mentioned are acid halide formers such as phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride or thionyl chloride; Anhydridtruckner such as ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulfonyl chloride; Carbodiimides such as N, N'-dicyclohexylcarbodiimide (DCC) or other conventional condensing agents such as phosphorus pentoxide, polyphosphoric acid, N, N'-carbonyldiimidazole, 2-ethoxy-N-
  • the processes (a), (f) and (g) according to the invention are carried out in the presence of a catalyst.
  • a catalyst examples which may be mentioned are 4-dimethylaminopyridine, 1-hydroxybenzotriazole or dimethylformamide.
  • reaction temperatures can be varied within a substantial range when carrying out the processes (a), (f) and (g) according to the invention. In general, one works at temperatures of 0 0 C to 150 0 C, preferably at temperatures of 0 0 C to 80 0 C.
  • Suitable diluents for carrying out the processes (b), (c) and (d) according to the invention are all inert organic solvents.
  • aliphatic, alicyclic or aromatic hydrocarbons such as, for example, petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; Ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; Nitriles, such as acetonitrile, propionitrile, n- or i-butyronitrile or benzonitrile; Amides such as N 5 N-dimethylformamide, N, N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethyl phosphoric acid triamide; Esters
  • reaction temperatures can be varied within a substantial range when carrying out the processes (b), (c) and (d) according to the invention. In general, one works at temperatures of 0 0 C to 180 0 C, preferably at temperatures of 20 0 C to 150 0 C.
  • the processes (b), (c) and (d) according to the invention are optionally carried out in the presence of a suitable acid acceptor.
  • a suitable acid acceptor As such, all customary inorganic or organic bases are suitable. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, fluorides, phosphates, carbonates or hydrogencarbonates, such as, for example, Sodium hydride, sodium amide, lithium diisopropylamide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium phosphate, potassium phosphate, potassium fluoride, cesium fluoride, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or cesium carbonate, and tertiary amines, such as trimethylamine, triethylamine, tributylamine, N, N-dimethylaniline,
  • a catalyst e.g. a palladium salt or complex.
  • a catalyst e.g. a palladium salt or complex.
  • a catalyst e.g. a palladium salt or complex.
  • a catalyst e.g. a palladium salt or complex.
  • a catalyst e.g. a palladium salt or complex.
  • palladium chloride, palladium acetate, tetrakis (triphenylphosphine) palladium, bis (triphenylphosphine) - palladium dichloride or (l, r-bis (diphenylphosphino) ferrocenpalladium ( ⁇ ) chloride come into question.
  • a palladium complex in the reaction mixture if a palladium salt and a complex ligand, for example triethylphosphine, tri-tert-butylphosphine, tricyclohexylphosphine, 2- (dicyclohexylphosphine) -biphenyl, 2- (di-tert-butylphosphine) biphenyl, 2- (dicy- clohexylphosphine) -2 '- (N, N-dimethylamino) -biphenyl, triphenylphosphine, tris (o-tolyl) -phosphine, sodium 3- (diphenylphosphino) benzenesulfonate, tris-2- (methoxyphenyl) -phosphine, 2,2 'Bis- (diphenylphosphine) -l, 1'-binaphthyl, 1,4-bis
  • Suitable diluents for carrying out the process (e) according to the invention are all inert organic solvents. These include, preferably, aliphatic, alicyclic or aromatic hydrocarbons, e.g. Petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; halogenated hydrocarbons, e.g.
  • Chlorobenzene dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or t-chloroethane; Ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole or amides, such as N, N-dimethylformamide, N, N- Dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide.
  • Ethers such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxye
  • the process (e) according to the invention is carried out in the presence of a base.
  • a base As such, all customary inorganic or organic bases are suitable. These preferably include alkaline earth metal or alkali metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates or bicarbonates, such as sodium hydride, sodium amide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, Ammonium hydroxide, sodium acetate, potassium acetate, calcium acetate, ammonium acetate, sodium carbonate, potassium carbonate, potassium hydrogen carbonate.
  • alkaline earth metal or alkali metal hydrides such as sodium hydride, sodium amide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, Ammonium hydroxide, sodium acetate, potassium acetate, calcium acetate, ammonium a
  • tertiary amines such as trimethylamine, triethylamine, tributylamine, N, N-dimethylaniline, N, N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclo- nonene (DBN) or diazabicycloundecene (DBU).
  • DABCO diazabicyclooctane
  • DBN diazabicyclo- nonene
  • DBU diazabicycloundecene
  • reaction temperatures can be varied within a substantial range when carrying out the process (e) according to the invention. In general, one works at temperatures of 0 0 C to 150 0 C, preferably at temperatures of 20 0 C to 110 0 C.
  • the substances according to the invention have a strong microbicidal activity and can be used for controlling unwanted microorganisms, such as fungi and bacteria, in crop protection and in the protection of materials.
  • Fungicides can be used for the control of Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes.
  • Bactericides can be used in crop protection for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
  • Xanthomonas species e.g. Xanthomonas campestris pv. Oryzae;
  • Pseudomonas species e.g. Pseudomonas syringae pv. Lachrymans;
  • Erwinia species e.g. Erwinia amylovora
  • Pythium species e.g. Pythium ultimum
  • Phytophthora species e.g. Phytophthora infestans
  • Pseudoperonospora species such as e.g. Pseudoperonospora humuli or
  • Plasmopara species such as Plasmopara viticola
  • Bremia species e.g. Bremia lactucae
  • Peronospora species e.g. Peronospora pisi or P. brassicae;
  • Erysiphe species e.g. Erysiphe graminis
  • Sphaerotheca species e.g. Sphaerotheca fuliginea
  • Podosphaera species e.g. Podosphaera leucotricha
  • Venturia species e.g. Venturia inaequalis
  • Pyrenophora species e.g. Pyrenophora teres or P. graminea
  • Cochliobolus species e.g. Cochliobolus sativus
  • Uromyces species e.g. Uromyces appendiculatus
  • Puccinia species e.g. Puccinia recondita
  • Sclerotinia species e.g. Sclerotinia sclerotiorum
  • Tilletia species e.g. Tilletia caries
  • Ustilago species e.g. Ustilago nuda or Ustilago avenae;
  • Pellicularia species e.g. Pellicularia sasakii;
  • Pyricularia species e.g. Pyricularia oryzae
  • Fusarium species e.g. Fusarium culmorum
  • Botrytis species e.g. Botrytis cinerea
  • Septoria species e.g. Septoria nodorum
  • Leptosphaeria species e.g. Leptosphaeria nodorum
  • Cercospora species e.g. Cercospora canescens
  • Alternaria species e.g. Alternaria brassicae
  • Pseudocercosporella species e.g. Pseudocercosporella he ⁇ otrichoides
  • Alternaria species e.g. Alternaria brassicae
  • Pseudocercosporella species e.g. Pseudocercosporella he ⁇ otrichoides
  • Rhizoctonia species e.g. Rhizoctonia solani.
  • the active compounds according to the invention also have a strong tonic effect in plants. They are therefore suitable for mobilizing plant-own defenses against attack by unwanted microorganisms.
  • plant-strengthening (resistance-inducing) substances are to be understood as meaning those substances which are capable of stimulating the defense system of plants in such a way that the treated plants, upon subsequent inoculation with unwanted microorganisms, display extensive resistance to these microorganisms.
  • Undesirable microorganisms in the present case are phytopathogenic fungi, bacteria and viruses.
  • the substances according to the invention can therefore be used to protect plants within a certain period of time after the treatment against the infestation by the said pathogens.
  • the period within which protection is provided generally extends from 1 to 10 days, preferably 1 to 7 days after the treatment of the plants with the active ingredients.
  • the good plant tolerance of the active ingredients in the necessary concentrations for controlling plant diseases allows treatment of aboveground plant parts, of plant and seed, and the soil.
  • the active compounds according to the invention can be used with particularly good success for controlling cereal diseases, such as, for example, against Puccinia species and diseases in the wine, fruit and vegetable growing, such. against Botrytis, Venturia or Alternaria species.
  • the active compounds according to the invention are also suitable for increasing crop yield. They are also low toxicity and have good plant tolerance.
  • the active compounds according to the invention may optionally also be used in certain concentrations and application amounts as herbicides, for influencing plant growth, and for controlling animal pests. If appropriate, they can also be used as intermediates and precursors for the synthesis of other active ingredients.
  • plants are understood as meaning all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants).
  • Cultivated plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant varieties which can or can not be protected by plant variety rights.
  • Plant parts are to be understood as meaning all aboveground and subterranean parts and organs of the plants, such as shoot, leaf, flower and root, examples of which include leaves, needles, stems, stems, flowers, fruiting bodies, fruits and seeds, and roots, tubers and rhizomes.
  • the plant parts also include crops and vegetative and generative propagation material, such as cuttings, tubers, rhizomes, offshoots and seeds.
  • the treatment according to the invention of the plants and plant parts with the active ingredients takes place directly or by acting on their environment, habitat or storage space according to the usual treatment methods, for example by dipping, spraying, evaporating, atomizing, spreading, spreading and in the case of propagation material, in particular in the case of seeds. furthermore by single or multi-layer wrapping.
  • the substances according to the invention can be used to protect industrial materials against infestation and destruction by undesired microorganisms.
  • Technical materials as used herein mean non-living materials that have been prepared for use in the art.
  • engineering materials to be protected from microbial alteration or destruction by actives of the present invention may be adhesives, glues, paper and board, textiles, leather, wood, paints and plastics, coolants, and other materials that infiltrate or degrade microorganisms can be.
  • the materials to be protected may also include parts of production plants, for example cooling water circuits, which may be adversely affected by the proliferation of microorganisms.
  • technical materials which may be mentioned are preferably adhesives, glues, papers and cartons, leather, wood, paints, cooling lubricants and heat transfer liquids, particularly preferably wood.
  • microorganisms that can cause degradation or a change in the technical materials, for example, bacteria, fungi, yeasts, algae and mucus organisms may be mentioned.
  • the active compounds according to the invention preferably act against fungi, in particular molds, wood-discolouring and wood-destroying fungi (Basidiomycetes) and against slime organisms and algae.
  • microorganisms of the following genera There may be mentioned, for example, microorganisms of the following genera:
  • Alternaria such as Alternaria tenuis, Aspergillus, such as Aspergillus niger,
  • Chaetomium such as Chaetomium globosum
  • Coniophora like Coniophora puetana,
  • Lentinus like Lentinus tigrinus
  • Penicillium such as Penicillium glaucum
  • Polyporus such as Polyporus versicolor
  • Aureobasidium such as Aureobasidium pullulans, Sclerophoma such as Sclerophoma pityophila, Trichoderma such as Trichoderraa viride, Escherichia such as Escherichia coli, Pseudomonas such as Pseudomonas aeruginosa, Staphylococcus such as Staphylococcus aureus.
  • the active compounds can be converted into the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols, very fine encapsulations in polymeric substances and in seed coating compositions, as well as ULV -KaIt- and warm mist formulations.
  • customary formulations such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols, very fine encapsulations in polymeric substances and in seed coating compositions, as well as ULV -KaIt- and warm mist formulations.
  • formulations are prepared in a known manner, for example by mixing the active compounds with extenders, ie liquid solvents, liquefied gases under pressure and / or solid carriers, optionally with the use of surface-active agents, ie emulsifiers and / or dispersants and / or foam-forming agents.
  • extenders ie liquid solvents, liquefied gases under pressure and / or solid carriers
  • surface-active agents ie emulsifiers and / or dispersants and / or foam-forming agents.
  • organic solvents as auxiliary solvents.
  • Suitable liquid solvents are essentially: aromatics, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example petroleum fractions, alcohols, such as butanol or glycol and their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as dimethylformamide and dimethyl sulfoxide, and water.
  • aromatics such as xylene, toluene or alkylnaphthalenes
  • chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride
  • Liquefied gaseous extenders or carriers are liquids which are gaseous at normal temperature and under atmospheric pressure, for example aerosol propellants, such as halogenated hydrocarbons, as well as butane, propane, nitrogen and carbon dioxide.
  • Suitable solid carriers are: for example ground natural minerals, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals, such as finely divided silica, alumina and silicates.
  • solid carriers for granules are: for example, broken and fractionated natural rocks such as calcite, pumice, marble, sepiolite, dolomite and synthetic granules of inorganic and organic flours and granules of organic material such as sawdust, coconut shells, corn cobs and tobacco stalks.
  • Suitable emulsifiers and / or foam-formers are: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulfonates, alkyl sulfates, arylsulfonates and protein hydrolysates.
  • Suitable dispersants are: for example lignin-sulphite liquors and methylcellulose.
  • Adhesives such as carboxymethylcellulose, natural and synthetic powdery, granular or latex-like polymers can be used in the formulations, such as gum arabic, polyvinyl alcohol, polyvinyl acetate, natural phospholipids such as cephalins and lecithins, and synthetic phospholipids.
  • Other additives may be mineral and vegetable oils.
  • Dyes such as inorganic pigments, e.g. Iron oxide, titanium oxide, ferrocyan blue and organic dyes such as alizarin, azo and metal phthalocyanine dyes and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • inorganic pigments e.g. Iron oxide, titanium oxide, ferrocyan blue and organic dyes such as alizarin, azo and metal phthalocyanine dyes and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • the formulations generally contain between 0.1 and 95% by weight of active ingredient, preferably between 0.5 and 90%.
  • the active compounds according to the invention can also be used in admixture with known fungicides, bactericides, acaricides, nematicides or insecticides, so as to obtain e.g. to broaden the spectrum of action or to prevent development of resistance.
  • synergistic effects i. E. the effectiveness of the mixture is greater than the effectiveness of the individual components.
  • Fungicides are suitable as mixed partners: Fungicides:
  • 2-phenylphenol 8-hydroxyquinoline sulfates; Acibenzolar-S-methyl; aldimorph; amidoflumet; Amphropolys; Ampropylfos-potassium; andoprim; anilazine; azaconazole; azoxystrobin; benalaxyl;
  • Benalaxyl-M Benodanil; benomyl; Benthiavalicarb-isopropyl; Benzamacril; Benzamacril-isobutyl;
  • bilanafos binapacryl; biphenyl; bitertanol; Blasticidin-S; boscalid; bromuconazole; Bupirimate; Buthiobate; butylamine; Calcium polysulfides; capsimycin; captafol; captan; carbendazim; carboxin;
  • Cyprofiiram Dagger G; debacarb; dichlofluanid; dichlone; dichlorophen; diclocymet; Diclomezine;
  • fenamidone Fenapanil; fenarimol; Fenbuconazole; fenfuram; fenhexamid; Fenitropan; fenoxanil;
  • fenpiclonil fenpropidin; Fenpropimo ⁇ h; ferbam; fluazinam; Flubenzimine; fludioxonil; flumetover;
  • Flumo ⁇ h Flumo ⁇ h; fluoromides; fluoxastrobin; fluquinconazole; Flu ⁇ rimidol; flusilazole; flusulfamide; Flutolanil; flutriafol; folpet; Fosetyl-Al; Fosetyl-sodium; fuberidazole; furalaxyl; Furametpyr, furcarbanil;
  • carbamates e.g., alanycarb, aldicarb, aldoxycarb, allyxycarb, aminocarb, azamethiphos,
  • organophosphates eg acephates, azamethiphos, azinphos (-methyl, -ethyl), bromophos-ethyl, bromfenvinfos (-methyl), butathiofos, cadusafos, carbophenothion, chloroethoxyfos, chlorfenvinophos, chloroforms, chlorpyrifos (-methyl / -ethyl), Coumaphos, cyanofenphos, cyanophos, chlorfenvinphos, demeton-S-methyl, demeton-S-methylsulphone, dialifos, diazinon, dichlofenthione, dichlorvos / DDVP, dicrotophos, dimethoates, dimethylvinphos, dioxabenzofos, disulphoton, EPN, ethion, ethoprophos, etrimfos, Famphur, Fenamiphos, Fenitro
  • Propetamphos prothiofos, prothoates, pyraclofos, pyridaphenthion, pyridathion, quinalphos, sebufos, sulfotep, sulprofos, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometone, triazophos, triclorfone, vamidothion)
  • Pyrethroids eg acrinathrin, allethrin (d-cis-trans, d-trans), beta-cyfluthrin, bifenthrin, biotethrin, bioallethrin-S-cyclopentyl isomer, bioethanomethrin, biopermethrin, bioresmethrin, chlorovaporthrin, cis-cypermethrin , Cis-resmethrin, cis-permethrin, clocthrin, cycloprothrin, cyfluthrin, cyhalothrin, cypermethrin (alpha-, beta-, theta-, zeta-), cyphenothrin, DDT, deltamethrin, pentan-in (IR-isomer), esfenvalerate , Etofenprox, fenfluthrin, fen
  • Oxadiazines e.g., indoxacarb
  • chloronicotinyls / neonicotinoids for example, acetamiprid, clothianidin, dinotefuran, imidacloprid, tenpyram, nithiazines, thiacloprid, thiamethoxam
  • Mectins e.g., abamectin, avermectin, emamectin, emamectin benzoate, ivermectin, milbe- mectin, milbemycin.
  • Juvenile hormone mimetics e.g., abamectin, avermectin, emamectin, emamectin benzoate, ivermectin, milbe- mectin, milbemycin.
  • Diacylhydrazines e.g., chromafenozides, halofenozides, methoxyfenozides, tebufenozides
  • Inhibitors of chitin biosynthesis e.g., chromafenozides, halofenozides, methoxyfenozides, tebufenozides
  • Benzoylureas e.g., bistrifluron, chlorofluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluron, teflubenzuron, trifluoronon
  • bistrifluron, chlorofluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluron, teflubenzuron, trifluoronon e.g., bistrifluron, chlorofluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron
  • Organotin e.g., azocyclotin, cyhexatin, fenbutatin oxides
  • METI's e.g., Fenazaquin, Fenpyroximate, Pyrimidifen, Pyridaben, Tebufenpyrad, Tolfenpyrad
  • Tetronic acids e.g., spirodiclofen, spiromesifen
  • 16.2 tetramic acids [eg 3- (2,5-dimethylphenyl) -8-methoxy-2-oxo-1-azaspiro [4.5] dec-3-en-4-yl ethyl carbonate (also known as: carbonic acid, 3- (2, 5-dimethylphenyl) -8-methoxy-2-oxo-l-azaspiro [4.5] dec-3-en-4- yl ethyl ester, CAS Reg.
  • Phthalamides eg, - [1- (3-dimethyl) -ethyl-1-methyl-1-methyl-1-methyl-4-trifluoromethyl) ethyl] -phenyl] -l, 2-benzenedicarboxamide (CAS Reg. No .: 272451-65-7), Flubendiamide)
  • Biologics, hormones or pheromones e.g., Azadirachtin, Bacillus spec, Beauveria spec, Codlemone, Metarrhicon spec, Paecilomyces spec, Thuringiensin, Verticillium spec
  • fumigants e.g., aluminum phosphides, methyl bromides, sulfuryl fluorides
  • Selective feeding inhibitors e.g., cryolites, flonicamid, pymetrozines
  • mite growth inhibitors e.g., clofentezines, etoxazoles, hexythiazox
  • the compounds of the formula (I) according to the invention also have very good antifungal effects on. They have a very broad antimycotic spectrum of activity, in particular against dermatophytes and yeasts, mold and diphasic fungi (eg against Candida species such as Candida albicans, Candida glabrata) and Epidermophyton floccosum, Aspergillus species such as Aspergillus niger and Aspergillus fumigatus, Trichophyton species such as Trichophyton mentagrophytes, Microsporon species such as Microsporon canis and audouinii.
  • Candida species such as Candida albicans, Candida glabrata
  • Epidermophyton floccosum Aspergillus species such as Aspergillus niger and Aspergillus fumigatus
  • Trichophyton species such as Trichophyton mentagrophytes
  • Microsporon species such as Microsporon canis and audouinii.
  • the list of these fungi is by no means
  • the active compounds can be used as such, in the form of their formulations or in the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules.
  • the application is done in the usual way, e.g. by pouring, spraying, spraying, scattering, dusting, foaming, spreading, etc. It is further possible whilbrin ⁇ the active ingredients by the ultra-low-volume method or to inject the active ingredient preparation or the active ingredient itself into the soil. It can also be the seed of the plants to be treated.
  • the application rates can be varied within a relatively wide range, depending on the mode of administration.
  • the application rates of active ingredient are generally between 0.1 and 10,000 g / ha, preferably between 10 and 1,000 g / ha.
  • the application rates of active ingredient are generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 10 g per kilogram of seed.
  • the application rates of active ingredient are generally between 0.1 and 10,000 g / ha, preferably between 1 and 5,000 g / ha.
  • plants and their parts can be treated.
  • wild-type or plant species obtained by conventional biological breeding methods such as crossing or protoplast fusion
  • plant cultivars and their parts are treated.
  • transgenic plants and plant cultivars obtained by genetic engineering if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof are treated.
  • the term “parts” or “parts of plants” or “plant parts” has been explained above.
  • Plant varieties are understood as meaning plants new traits that have been bred either by conventional breeding, by mutagenesis or by recombinant DNA techniques, which may be varieties, breeds, biotypes and genotypes.
  • super-additive effects may also occur as a result of the treatment according to the invention.
  • super-additive effects may also occur as a result of the treatment according to the invention.
  • reduced application rates and / or extensions of the activity spectrum and / or a Enhancement of the effect of the substances and agents which can be used according to the invention better plant growth, increased tolerance to high or low temperatures, increased tolerance to dryness or to water or soil salt content, increased flowering efficiency, easier harvest, acceleration of ripeness, higher crop yields, higher quality and / or higher nutritional value of the harvested products, higher shelf life and / or workability of the harvested products possible, which go beyond the actual expected effects.
  • the preferred plants or plant varieties to be treated according to the invention which are to be treated include all plants which have obtained genetic material by the genetic engineering modification which gives these plants particularly advantageous valuable properties ("traits") Examples of such properties are better Plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering, easier harvesting, acceleration of maturity, higher crop yields, higher quality and / or higher nutritional value of the harvested products, higher shelf life and Further and particularly emphasized examples of such properties are an increased defense of the plants against animal and microbial pests, such as insects, mites, phytopathogenic fungi, bacteria and / or Viruses and increased tolerance of plants against certain herbicidal active ingredients.
  • microbial pests such as insects, mites, phytopathogenic fungi, bacteria and / or Viruses and increased tolerance of plants against certain herbicidal active ingredients.
  • transgenic plants include the important crops such as cereals (wheat, rice), corn, soybean, potato, cotton, tobacco, oilseed rape and fruit plants (with the fruits apples, pears, citrus fruits and grapes), with corn, soybean, potato , Cotton, tobacco and oilseed rape.
  • Bt plants are the increased defense of the plants against insects, arachnids, nematodes and snails by toxins produced in the plants, in particular those which are produced by the genetic material from Bacillus thuringiensis (eg by the genes Cry ⁇ A (a) , CrylA (b), Cry ⁇ A (c), CryllA, CrylHA, CryHTB2, Cry9c Cry2Ab, Cry3Bb and CrylF and combinations thereof) in the plants (hereinafter "Bt plants”).
  • Bacillus thuringiensis eg by the genes Cry ⁇ A (a) , CrylA (b), Cry ⁇ A (c), CryllA, CrylHA, CryHTB2, Cry9c Cry2Ab, Cry3Bb and CrylF and combinations thereof
  • traits are also particularly emphasized the increased defense of plants against fungi, bacteria and viruses Systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and correspondingly expressed proteins and toxins. Traits which are furthermore particularly emphasized are the increased tolerance of the plants to certain herbicidal active substances, for example imidazolinones, sulfonylureas, glyphosate or phosphinotricin (eg "PAT" gene), each of which has the desired properties (“traits"). conferring genes may also occur in combinations with each other in the transgenic plants.
  • SAR Systemic acquired resistance
  • PAT phosphinotricin
  • Examples of “3t plants” are maize varieties, cotton varieties, soybean varieties and potato varieties which are sold under the trade names YIELD GARD® (eg maize, cotton, soya), KnockOut® (eg maize), StarLink® (eg maize), Bollgard Examples of herbicide-tolerant plants are maize varieties, cotton varieties and soybean varieties, which are sold under the trade names Roundup Ready® (tolerance to glyphosate, eg corn, cotton , Soya), Liberty Link® (tolerance to phosphinotricin, eg rapeseed), IMI® (tolerance to imidazolinone) and STS® (tolerance to sulfonylureas eg corn) are also herbicide resistant (conventionally grown on herbicide tolerance) plants
  • Clearfield® eg maize
  • these statements also apply to Pf developed or to be marketed in the future varieties of lances with these or future developed genetic traits.
  • the listed plants can be treated particularly advantageously according to the invention with the compounds of the general formula (I) or the active substance mixtures according to the invention.
  • the preferred ranges given above for the active compounds or mixtures also apply to the treatment of these plants. Particularly emphasized is the plant treatment with the compounds or mixtures specifically mentioned in the present text.
  • the specified logP values were determined in accordance with EEC Directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on a phase inversion column (C 18). Temperature: 43 ° C.
  • Eluents for determination in the acidic range (pH 2.3): 0.1% aqueous phosphoric acid, acetonitrile; linear gradient from 10% acetonitrile to 90% acetonitrile.
  • the calibration was carried out with unbranched alkan-2-ones (with 3 to 16 carbon atoms) whose LogP values are known (determination of the LogP values by means of the retention times by linear interpolation between two consecutive alkanones).
  • the lambda max values were determined on the basis of the UV spectra from 200 nm to 400 nm in the maxima of the chromatographic signals.
  • Emulsifier 1 part by weight of alkyl-aryl-polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • dimethylacetamide emulsifier 1 part by weight of alkyl-aryl-polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • the plants are then placed in the greenhouse at about 21 0 C and a relative humidity of about 90%.
  • dimethylacetamide emulsifier 1 part by weight of alkyl-aryl-polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • Emulsifier 1 part by weight of alkylaryl polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • the plants are then placed in a greenhouse at a temperature of about 20 0 C and a relative humidity of 80%.
  • Emulsifier 1 part by weight of alkylaryl polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

L'invention concerne de nouveaux biphényl-thiazol-carboxamides de formule (I), dans laquelle R<sup
EP05770051A 2004-08-27 2005-08-13 Biphenyl-thiazol-carboxamides Withdrawn EP1786794A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041530A DE102004041530A1 (de) 2004-08-27 2004-08-27 Biphenylthiazolcarboxamide
PCT/EP2005/008837 WO2006024387A2 (fr) 2004-08-27 2005-08-13 Biphenyl-thiazol-carboxamides

Publications (1)

Publication Number Publication Date
EP1786794A2 true EP1786794A2 (fr) 2007-05-23

Family

ID=35745599

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05770051A Withdrawn EP1786794A2 (fr) 2004-08-27 2005-08-13 Biphenyl-thiazol-carboxamides

Country Status (11)

Country Link
US (1) US7977363B2 (fr)
EP (1) EP1786794A2 (fr)
JP (1) JP2008510744A (fr)
KR (1) KR20070053275A (fr)
CN (2) CN103145640A (fr)
AR (1) AR050515A1 (fr)
BR (1) BRPI0514678A (fr)
CA (1) CA2578007C (fr)
DE (1) DE102004041530A1 (fr)
MX (1) MX2007002242A (fr)
WO (1) WO2006024387A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10246959A1 (de) * 2002-10-09 2004-04-22 Bayer Cropscience Ag Thiazolylbiphenylamide
DE102004005786A1 (de) * 2004-02-06 2005-08-25 Bayer Cropscience Ag Haloalkylcarboxamide
DE102004041532A1 (de) * 2004-08-27 2006-03-02 Bayer Cropscience Ag Biphenylthiazolcarboxamide
DE102004059725A1 (de) * 2004-12-11 2006-06-22 Bayer Cropscience Ag 2-Alkyl-cycloalk(en)yl-carboxamide
DE102005022147A1 (de) * 2005-04-28 2006-11-02 Bayer Cropscience Ag Wirkstoffkombinationen
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
JP5637982B2 (ja) * 2008-04-09 2014-12-10 インフィニティー ファーマシューティカルズ， インコーポレイテッド 脂肪酸アミド加水分解酵素の阻害剤
CA2757679A1 (fr) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibiteurs d'amide d'hydrolase d'acide gras
WO2010118159A1 (fr) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibiteurs d'hydrolase d'amide d'acide gras
BR112012019120A2 (pt) 2010-02-03 2016-06-28 Infinity Pharmaceuticais Inc forma sólida, composição farmacêutica, método de preparação do composto 1, método de tratamento de uma condição mediada por faah
ES2893100T3 (es) 2015-10-12 2022-02-08 Advanced Cell Diagnostics Inc Detección in situ de variantes de nucleótidos en muestras con un elevado nivel de ruido, y composiciones y métodos relacionados con ésta
TWI696615B (zh) * 2016-05-05 2020-06-21 瑞士商伊蘭科動物健康公司 雜芳基-1,2,4-三唑及雜芳基-三唑化合物
EP4198033A1 (fr) * 2021-12-14 2023-06-21 Basf Se Composés hétérocycliques destinés à la lutte contre les organismes nuisibles invertébrés
WO2023110473A1 (fr) 2021-12-14 2023-06-22 Basf Se Composés hétérocycliques pour la lutte contre les nuisibles invertébrés

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3547917A (en) 1966-12-07 1970-12-15 Uniroyal Inc 2-amino-4-methylthiazole-5-carboxamides
US5045554A (en) 1988-11-29 1991-09-03 Monsanto Company Substituted thiazoles and their use as fungicides
IL103614A (en) 1991-11-22 1998-09-24 Basf Ag Carboxamides for controlling botrytis and certain novel such compounds
DE4231517A1 (de) 1992-09-21 1994-03-24 Basf Ag Carbonsäureanilide, Verfahren zu ihrer Herstellung und sie enthaltende Mittel zur Bekämpfung von Schadpilzen
DE4231519A1 (de) 1992-09-21 1994-03-24 Basf Ag Cyclohex(en)ylcarbonsäureamide, Verfahren zu ihrer Herstellung und sie enthaltende Mittel zur Bekämpfung von Schadpilzen
JPH08176112A (ja) 1994-12-22 1996-07-09 Mitsui Toatsu Chem Inc Ｎ，ｎ−ジ置換アニリン誘導体およびこれを有効成分とする農園芸用殺菌剤
GB9510459D0 (en) 1995-05-24 1995-07-19 Zeneca Ltd Bicyclic amines
US5633218A (en) 1995-05-24 1997-05-27 E. I. Du Pont De Nemours And Company Herbicidal benzodioxoles and benzodioxanes
DE19531813A1 (de) * 1995-08-30 1997-03-06 Basf Ag Bisphenylamide
GB9624611D0 (en) 1996-11-26 1997-01-15 Zeneca Ltd Bicyclic amine compounds
AU7200300A (en) * 1999-12-16 2001-06-21 Rohm And Haas Company 5-carboxanilido-haloalkylthiazoles as antimicrobial and marine antifouling agents
JP2001302605A (ja) 2000-04-20 2001-10-31 Sumitomo Chem Co Ltd ビフェニル化合物およびその用途
GB0012671D0 (en) 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
GB0101996D0 (en) 2001-01-25 2001-03-14 Syngenta Participations Ag Organtic compounds
DE10204390A1 (de) 2002-02-04 2003-08-14 Bayer Cropscience Ag Disubstituierte Thiazolylcarboxanilide
DE10204391A1 (de) * 2002-02-04 2003-08-14 Bayer Cropscience Ag Difluormethylthiazolylcarboxanilide
DE10215292A1 (de) 2002-02-19 2003-08-28 Bayer Cropscience Ag Disubstitutierte Pyrazolylcarbocanilide
DE10246959A1 (de) 2002-10-09 2004-04-22 Bayer Cropscience Ag Thiazolylbiphenylamide
DE10250110A1 (de) * 2002-10-28 2004-05-13 Bayer Cropscience Ag Thiazol-(bi)cycloalkyl-carboxanilide
DE10347090A1 (de) 2003-10-10 2005-05-04 Bayer Cropscience Ag Synergistische fungizide Wirkstoffkombinationen
DE10349501A1 (de) * 2003-10-23 2005-05-25 Bayer Cropscience Ag Synergistische fungizide Wirkstoffkombinationen
DE102004041532A1 (de) * 2004-08-27 2006-03-02 Bayer Cropscience Ag Biphenylthiazolcarboxamide
DE102005060462A1 (de) * 2005-12-17 2007-06-28 Bayer Cropscience Ag Biphenylcarboxamide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006024387A2 *

Also Published As

Publication number Publication date
BRPI0514678A (pt) 2008-06-17
WO2006024387A2 (fr) 2006-03-09
CN101065369A (zh) 2007-10-31
US7977363B2 (en) 2011-07-12
CA2578007C (fr) 2013-04-16
CN103145640A (zh) 2013-06-12
KR20070053275A (ko) 2007-05-23
JP2008510744A (ja) 2008-04-10
DE102004041530A1 (de) 2006-03-02
AR050515A1 (es) 2006-11-01
MX2007002242A (es) 2007-04-23
US20080242708A1 (en) 2008-10-02
CA2578007A1 (fr) 2006-03-09
WO2006024387A3 (fr) 2006-05-11

Similar Documents

Publication Publication Date Title
EP1713789B1 (fr) 2-halogenofuryl/thienyl-3-carboxamides
EP1716099B1 (fr) Haloalkylcarboxamides pour combattre les microorganismes
EP1771069B1 (fr) Derives de n-(2-(hydroxymethyl)phenyl)-1h-pyrazolo-4-carboxamide et composes apparentes utilises comme substances actives microbicides dans la protection phytosanitaire et la protection des materiaux
WO2006024389A2 (fr) Biphenyl thiazol carboxamides
EP1786794A2 (fr) Biphenyl-thiazol-carboxamides
DE102005009458A1 (de) Pyrazolylcarboxanilide
DE102005007534A1 (de) Pyrazolopyrimidine
EP1727816B1 (fr) Carboxamides silyles microbicides
EP1590330A1 (fr) Pyrazolylcarboxanilides pour lutter contre des micro-organismes indesirables
WO2005066138A1 (fr) Amides heterocycliques substitues a effet fongicide
EP1480516B1 (fr) Agents microbicides a base de derives de biphenyle benzamide
DE102004059725A1 (de) 2-Alkyl-cycloalk(en)yl-carboxamide
WO2005058839A1 (fr) Carboxamides optiquement actifs et leur utilisation pour lutter contre des micro-organismes indesirables
WO2005049624A1 (fr) Carboxamides silyles
WO2004072023A2 (fr) Oxathiine-carboxamides
WO2005077952A1 (fr) Imidazolopyrimidines
EP1694681B1 (fr) Pyrazolopyrimidines
EP1501820B1 (fr) Methylthiophenocarboxa nilides
EP2049496A2 (fr) 3-difluorométhyl-pyrazolylcarboxanilide
EP1694682A1 (fr) 7-amino-5-halopyrazolopyrimidine a action fongicide
EP1697372B1 (fr) Pyrazolopyrimidines
EP1694680A1 (fr) Pyrazolopyrimidines
MXPA06008881A (en) N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070327

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20120111

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140531